MedTrace Logo

PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing

NCT00409916 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2009-06-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether outpatient therapeutic management guided by impedance cardiography (ICG), in addition to standard clinical assessment, will result in a longer time in days to the first heart failure hospitalization than therapy guided by clinical assessment alone.

Conditions

  • Heart Failure, Congestive

Interventions

DEVICE

BioZ Dx

Sponsors & Collaborators

  • CardioDynamics

    lead INDUSTRY

Principal Investigators

  • Milton Packer, MD · University of Texas Southwestern Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2011-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00409916 on ClinicalTrials.gov